Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CelAgace™ OraRinse (CAOR) Pilot Clinical Study for Management of Candidiasis Associated With Grade 0-II Mucositis

NCT03250923 is registered in ClinicalTrials.gov with CelaCare Technologies, Inc. as lead sponsor.

NCT NCT03250923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03250923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CelAgace™ OraRinse (CAOR) Pilot Clinical Study for Management of Candidiasis Associated With Grade 0-II Mucositis
Lead sponsor
CelaCare Technologies, Inc.
Phase
Phase 1/2
Overall status
Unknown status
Start date
September 30, 2024
Completion date
May 31, 2025
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

candidiasis, oral